August 8, 2024
The cost-effectiveness of a controversial test promoted as a multicancer early detection (MCED) tool from a single blood sample has been scrutinised in an investigation by […]
August 8, 2024
TOPLINE: Over half of patients with symptoms of gastroparesis have low vitamin D levels, which is linked to heightened nausea, vomiting, and gastric neuromuscular dysfunction. METHODOLOGY: […]
August 8, 2024
TOPLINE: While most potassium-competitive acid blockers demonstrate superior healing rates than proton pump inhibitors (PPIs) in patients with erosive esophagitis, both types of treatment offer relief […]
August 8, 2024
Mission The mission of the Controlled Substance Staff (CSS) is to promote the public health through the medical science-based assessment and management of drug abuse risks. […]
August 8, 2024
Controlled Substance Staff Functional Roles | FDA In this section: CDER Offices and Divisions Home About FDA FDA Organization Center for Drug Evaluation and Research (CDER) […]
August 8, 2024
TOPLINE: Both chronic and new-onset anxiety are linked to a threefold increased risk for dementia onset in later life, new research shows. METHODOLOGY: A total of […]
August 8, 2024
Docket Number: FDA-2018-D-0342 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Center for Biologics Evaluation and Research This guidance provides recommendations for the […]
August 8, 2024
TOPLINE: Breast cancer immunotherapy trials yield modest clinical impact, with a quarter of trials failing to report their outcomes, particularly among single-center studies which are more […]
August 8, 2024
TOPLINE: Elevated depression symptoms are linked to an increased risk for severe chemotherapy toxicity in older adults with cancer. This risk is mitigated by geriatric assessment […]